5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | Patent Publication Number 20200291004
US 20200291004 A1Patent NumberUS 11014917 B2
Application Number16890331
Filled DateJun 2, 2020
Priority DateAug 21, 2017
Publication DateSep 17, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsGee-Hong Kuo
Micheal Gaul
Guozhang Xu
Micheal Gaul
Guozhang Xu
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.